ATE110566T1 - Topische vaginal-verwendung von lysin p- isobutylphenylpropionat zur entzündungshemmenden behandlung. - Google Patents

Topische vaginal-verwendung von lysin p- isobutylphenylpropionat zur entzündungshemmenden behandlung.

Info

Publication number
ATE110566T1
ATE110566T1 AT87106201T AT87106201T ATE110566T1 AT E110566 T1 ATE110566 T1 AT E110566T1 AT 87106201 T AT87106201 T AT 87106201T AT 87106201 T AT87106201 T AT 87106201T AT E110566 T1 ATE110566 T1 AT E110566T1
Authority
AT
Austria
Prior art keywords
isobutylphenylpropionate
lysine
treatment
patients
vaginal
Prior art date
Application number
AT87106201T
Other languages
English (en)
Inventor
Giorgio Zagnoli
Original Assignee
Lisapharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lisapharma Spa filed Critical Lisapharma Spa
Application granted granted Critical
Publication of ATE110566T1 publication Critical patent/ATE110566T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87106201T 1986-06-16 1987-04-29 Topische vaginal-verwendung von lysin p- isobutylphenylpropionat zur entzündungshemmenden behandlung. ATE110566T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT20797/86A IT1190348B (it) 1986-06-16 1986-06-16 Impiego topico vaginale del p-isobutilfenilpropionato di lisina nel trattamento antiinfiammatorio

Publications (1)

Publication Number Publication Date
ATE110566T1 true ATE110566T1 (de) 1994-09-15

Family

ID=11172205

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87106201T ATE110566T1 (de) 1986-06-16 1987-04-29 Topische vaginal-verwendung von lysin p- isobutylphenylpropionat zur entzündungshemmenden behandlung.

Country Status (8)

Country Link
US (1) US4755533A (de)
EP (1) EP0253083B1 (de)
JP (1) JPS62298527A (de)
AT (1) ATE110566T1 (de)
CA (1) CA1288332C (de)
DE (1) DE3750447T2 (de)
ES (1) ES2058072T3 (de)
IT (1) IT1190348B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7404967B2 (en) 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
AU4861196A (en) * 1995-02-03 1996-08-21 Cosmederm Technologies Formulations and methods for reducing skin irritation
KR100206660B1 (ko) * 1996-08-13 1999-07-01 이종훈 열교환기 전열면의 부착물 감시장치 및 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1059677B (it) * 1974-03-22 1982-06-21 Neopharmed Spa Sale di lisina ad azione terapeutica

Also Published As

Publication number Publication date
IT1190348B (it) 1988-02-16
EP0253083B1 (de) 1994-08-31
IT8620797A1 (it) 1987-12-16
ES2058072T3 (es) 1994-11-01
EP0253083A2 (de) 1988-01-20
IT8620797A0 (it) 1986-06-16
CA1288332C (en) 1991-09-03
DE3750447D1 (de) 1994-10-06
EP0253083A3 (en) 1990-05-16
JPS62298527A (ja) 1987-12-25
US4755533A (en) 1988-07-05
DE3750447T2 (de) 1995-01-26

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
FI901285A0 (fi) Laite tahattoman virtsaamisen estämiseksi
OA08617A (fr) Inhibiteurs de métalloendopeptidase neutre dans le traitement de l'hypertention.
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
ATE62414T1 (de) Mittel zur behandlung von herzerkrankungen.
DE3750934D1 (de) Behandlung von nicht-Akne-entzündlichen und -infektiösen Hautkrankheiten.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE59007531D1 (de) Verwendung des Wirkstoffs Azelastin zur Bekämpfung von Psoriasis-Erkrankungen.
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
ATE77554T1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
NO913129L (no) Nytt trombolytisk middel.
ATE148628T1 (de) 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
ATE110566T1 (de) Topische vaginal-verwendung von lysin p- isobutylphenylpropionat zur entzündungshemmenden behandlung.
ES2073391T3 (es) Metodo y composiciones terapeuticas para el tratamiento de trastornos de perdidas de sangre.
ES2058203T3 (es) Derivados del acido pirocatequincarboxilico, su obtencion y empleo como substancias activas para medicamentos.
DE3674321D1 (de) Behandlung geschmeidiger gewebe.
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
RU2014020C1 (ru) Способ лечения стилоидита
ATE128358T1 (de) Therapeutische mittel für diabetisches gangrän.
McClure et al. A statistical study of minor industrial burns
SU628904A1 (ru) Способ обезболивани
UA15579A (uk) Раhозагоювальhий засіб
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
Kamaeva et al. Influence of current study load and examinations on the character of sympathetic-adrenal system reactions of students

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties